Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-17011915Phase 4Not yet recruiting
Phase 4, open-label trial of sevoflurane, desflurane and propofol in post-operative cognitive decline (POCD) and Emergence agitation (EA) (5 arms), sponsored by The First Affiliated Hospital of the University of South China. Primary endpoints: Incidence of emergence agitation, 5-point agitation scale score and 8 more. Planned start Jan 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-17011915.